Skip to main content
NOVANTA INC logo

NOVANTA INC — Investor Relations & Filings

Ticker · NOVT ISIN · CA67000B1040 LEI · 549300C0GFWBSFMPFD71 US Manufacturing
Open in API
Filings indexed 1,049 across all filing types
Latest filing 2017-11-28 Major Shareholding Noti…
Country US United States of America
Listing US NOVT

About NOVANTA INC

https://www.novanta.com/

Novanta Inc. is a global supplier of core technology solutions for original equipment manufacturers (OEMs) in the medical, life sciences, and advanced manufacturing markets. The company specializes in developing and manufacturing mission-critical components and subsystems based on its expertise in precision motion, photonics, and vision technologies. Its portfolio includes laser and beam steering engines, precision motion and robotic technologies, vision systems, and integrated operating room solutions. Novanta partners with OEMs to provide embedded solutions that solve complex technical challenges in demanding applications, enhancing system performance and enabling innovation.

Recent filings

Filing Released Lang Actions
SC 13D/A
Major Shareholding Notification
2017-11-28 English
10-Q
Interim / Quarterly Report Q3 2017
2017-11-01 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 1, 2017, by Novanta Inc. It announces the issuance of a press release containing financial results for the third quarter ended September 29, 2017. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release as an exhibit. The length of the document is 3220 characters, which is relatively short and consistent with an announcement rather than a full report. According to the 'Menu vs Meal' rule, this is an announcement of financial results, not the full earnings release or quarterly report itself. Therefore, the appropriate classification is Earnings Release (ER), as the document announces quarterly financial results.
2017-11-01 English
8-K/A
Regulatory Filings Classification · 95% confidence The document is a Form 8-K/A (amendment to a Form 8-K) filed with the SEC, reporting the acquisition of W.O.M. World of Medicine GmbH by Novanta Inc. It includes financial statements of the acquired business and pro forma financial information. The document is an SEC current report amendment, which is a regulatory filing to update or amend previously filed information. It is not a full annual or quarterly report, nor is it a standalone audit report or earnings release. The document length is 4414 characters, which is relatively short and consistent with a regulatory filing rather than a full report. The content focuses on acquisition disclosure and related financial information as exhibits, typical of a regulatory filing (RNS). Therefore, the appropriate classification is Regulatory Filings (RNS).
2017-09-14 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 1, 2017, reporting a material definitive agreement amendment related to the company's credit agreement. The content focuses on changes to the revolving credit facility and term loan balance, which are financing activities. There are no financial statements or earnings data presented, only details about the amendment to the credit agreement. This fits the category of Capital/Financing Update (CAP). The document length is 5786 characters, which is sufficient to contain substantive information rather than just an announcement. Therefore, the classification is CAP with high confidence.
2017-08-03 English
10-Q
Interim / Quarterly Report Q2 2017
2017-08-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.